EP3362477
MÓTEFNAVAKA-BINDANDI PRÓTÍN SEM VIRKJA LEPTÍNVIÐTAKANN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.10.2016EP published:
5.1.2022EP application number:
16785072.6
EP translation filed:
24.2.2022Grant published:
15.4.2022EPO information:
European Patent Register
Max expiry date:
10.10.2036Expiry date:
10.10.2026Next due date:
31.10.2026
Title in English:
ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTORLanguage of the patent:
English
Timeline
Today
11.10.2016EP application
5.1.2022EP Publication
24.2.2022Translation submitted
15.4.2022Registration published
10.10.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
Inventor
Name:
GROMADA, JesperAddress:
Concord, MA 01742, US
Name:
STEVIS, PanayiotisAddress:
Tarrytown, New York 10591, US
Name:
ALTAREJOS, JudithAddress:
Tarrytown, New York 10591, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201562240021 PDate:
12.10.2015Country:
US
Number:
201662359757 PDate:
8.7.2016Country:
US
Number:
201662375495 PDate:
16.8.2016Country:
US
Number:
201662393143 PDate:
12.9.2016Country:
US
Classification
Categories:
C07K 16/28, A61P 3/00, A61P 3/10, A61P 25/28, A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 20.9.2022
Expires: 10.10.2023
Payer: Patice ehf.
Number: 8
Paid: 6.10.2023
Expires: 10.10.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.9.2024
Expires: 10.10.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.10.2025
Expires: 10.10.2026
Payer: Árnason Faktor ehf.